Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
A. Caraman et al. / Journal of Advanced Research in Physics 6(1), 011601 (2016) 1 A Comparison Between 3D Conformal Radiotherapy, Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy Techniques for Head and Neck Cancer Andrei Caraman1,*, Călin Gheorghe Buzea2, Silviana Ojica1,2, Mihaela Oprea1,2, Alexandru Dumitru Zara1,2 and Dragoș Teodor Iancu1,3 Faculty of Physics, “Alexandru Ioan Cuza” University of Iași, Romania Radiotherapy Department, Regional Institute of Oncology, Iași, Romania 3 University of Medicine and Pharmacy „Grigore T. Popa”, Iași, Romania 1 2 I. INTRODUCTION Abstract — Although 3D Conformal Radiotherapy (3DCRT) is the current standard technique in the treatment of head and neck cancer, Intensity Modulated Radiotherapy (IMRT) and the newly developed Volumetric Modulated Arc Therapy (VMAT) are becoming increasingly used. VMAT is an advanced form of IMRT that was introduced in 2007. Volumetric Modulated Arc Therapy (VMAT) uses special software and an advanced linear accelerator to deliver Intensity Modulated Radiotherapy (IMRT) treatments up to eight times faster than what was previously possible. The present study compares treatment planning for a head and neck cancer case using 3D Conformal Radiotherapy (3DCRT), Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Radiotherapy (IMRT) techniques to find out which method is most suitable in terms of target volume coverage and preservation of organs at risk. The delivery of radiotherapy is challenging due to the large size and constraints of normal surrounding structures. Volumetric modulated arc therapy (VMAT) allows for rapid delivery of highly conformal dose distributions. To compare the Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Radiotherapy (IMRT) plans to the original 3D Conformal Radiotherapy (3DCRT) plan, dose-volume histograms (DVHs) were used. To visualize the differences, average cumulative Dose Volume Histograms (DVH) were calculated per examined tumor region for each organ and treatment technique. For each patient 3D Conformal Radiotherapy (3DRCT), Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) plans were generated and the Conformity Index (CI), organ at risk (OAR) doses and monitor unit (MU) were evaluated. The investigation for head and neck cancer case using Volumetric Modulated Arc Therapy (VMAT) technique proved a significant sparing of organs at risk and healthy tissue without compromising Planning Target Volume (PTV) coverage compared to 3D Conformal Radiotherapy (3DCRT). Keywords — 3D Conformal Radiotherapy, Intensity Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Treatment Planning Manuscript received May 11, 2016. *Corresponding author ([email protected]) RADIATION therapy or radiotherapy, often abbreviated RT, RT-x, or XRT, is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells [1]. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor (for example, early stages of breast cancer) [2]. Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. Head and neck cancer is cancer that starts in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx, larynx or parotid glands. Most head and neck cancers are biologically similar [3]. Around 90% of head and neck cancers are squamous cell carcinomas, so they are called head and neck squamous cell carcinomas (HNSCC) [2]. These cancers commonly originate from the mucosal lining (epithelium) of these regions. Head and neck cancers often spread to the lymph nodes of the neck, and this is often the first (and sometimes only) sign of the disease at the time of diagnosis. Head and neck cancer is strongly associated with certain environmental and lifestyle risk factors, including tobacco smoking, alcohol consumption, UV light, particular chemicals used in certain workplaces, and certain strains of viruses, such as human papillomavirus [4]. These cancers are frequently aggressive in their biologic behavior; patients with these types of cancer are at a higher risk of developing another cancer in the head and neck area. Radiotherapy (RT) plays an important role in the treatment of oropharyngeal cancer that is inoperable due to size or anatomical location [5]. We compared the performance of 3D conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc radiotherapy (VMAT) to evaluate the best treatment technique for 2 A. Caraman et al. / Journal of Advanced Research in Physics 6(1), 011601 (2016) inoperable large volume oropharyngeal cancer. A comparison of the Homogeneity Index (defined as (D2%D98%)/D50% (ICRU 83)), Conformity Index (defined as the ratio between the volume receiving at least 95 % of the prescribed dose and the PTV (ICRU 62)), OAR doses, monitor units (MUs) and treatment delivery time was evaluated. II. MATERIALS AND METHODS The planning of radiation therapy treatment has been revolutionized by the ability to delineate tumors and adjacent normal structures in three dimensions using specialized Computed tomography (CT) and/or Magnetic Resonance Imaging (MRI) scanners and planning software. Virtual simulation, the most basic form of planning, allows more accurate placement of radiation beams than is possible using conventional X-rays, where soft-tissue structures are often difficult to assess and normal tissues difficult to protect [5]. An enhancement of virtual simulation is 3-dimensional conformal radiation therapy (3DCRT), in which the profile of each radiation beam is shaped to fit the profile of the target from a beam's eye view (BEV) using a multileaf collimator (MLC) and a variable number of beams. When the treatment volume conforms to the shape of the tumor, the relative toxicity of radiation to the surrounding normal tissues is reduced, allowing a higher dose of radiation to be delivered to the tumor than conventional techniques would allow [6]. An example can be seen in Figure 1 where the radiation beams are set for one of the examined patients. Intensity modulated radiation therapy (IMRT) is an advanced type of high-precision radiation that is the next generation of 3D Conformal Radiotherapy. IMRT also improves the ability to conform the treatment volume to concave tumor shapes, for example when the tumor is wrapped around a vulnerable structure such as the spinal cord or a major organ or blood vessel [7]. Computercontrolled x-ray accelerators distribute precise radiation doses to malignant tumors or specific areas within the tumor. The pattern of radiation delivery is determined using highly tailored computing applications to perform optimization and treatment simulation (Treatment Planning). The radiation dose is consistent with the 3-D shape of the tumor by controlling, or modulating, the radiation beam’s intensity. The radiation dose intensity is elevated near the gross tumor volume while radiation among the neighboring normal tissue is decreased or avoided completely [8]. This results in better tumor targeting, lessened side effects, and improved treatment outcomes than even 3D Conformal Radiotherapy. The beam setup in IMRT planning and also the better coverage of tumor can be seen in Figure 2. Volumetric modulated arc therapy (VMAT) is a new radiation technique, which can achieve highly conformal dose distributions on target volume coverage and sparing of normal tissues. The specificity of this technique is to modify the three parameters during the treatment. Volumetric modulated arc therapy delivers radiation by rotating gantry Fig. 1. 3D-CRT plan beam setup. Fig. 2. Beam setup in IMRT planning. Fig. 3. Volumetric Modulated Arc Therapy arc setup. (usually 360° rotating fields with one or more arcs), changing speed and shape of the beam with a multileaf collimator (MLC) ("sliding window" system of moving) and fluency output rate (dose rate) of the medical linear accelerator [9]. VMAT also has the potential to give additional advantages in patient treatment, such as reduced delivery time of radiation, compared with conventional static A. Caraman et al. / Journal of Advanced Research in Physics 6(1), 011601 (2016) 3 field intensity modulated radiotherapy (IMRT) [9]. The manner in which the treatment is delivered to the patient is shown in Figure 3. III. RESULTS Our study analyzes the plans of treatment for 5 patients with the age range from 20 to 64. Two subjects were female and three were male. Patients were immobilized with a thermoplastic mask in the supine position followed by computed tomography (CT) scanning. The CT slices were acquired every 3 mm. The 3D Conformal Radiotherapy, Volumetric Modulated Radiotherapy and Intensity Modulated Radiotherapy plans were created using the same 6 MV photon beams commissioned for a Varian Clinac iX equipped with a 120 leaf Millennium MLC and variable dose rate up to 600 MU/s. The treatment plans were generated using the TPS (Treatment Planning System) Eclipse (version 11) and Analitical Anisotropic Algorithm. For the corresponding Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy plans we used ArcCheck 3D diode array from Sun Nuclear to check the dosimetric accuracy. All cancers were large; a feature which made surgery a less desirable treatment modality, with the Planning Target Volume ranging from 417-745 cm3. The minimum dose to the Planning Target Volume was significantly lower for 3D Conformal Radiotherapy compared to Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy plans, while there was small difference in the maximum or mean dose to Planning Target Volume. Due to significant inter-individual variability in the homogeneity index within each plan type (particularly for Volumetric Modulated Arc Therapy), the overall homogeneity index was statistically similar for the three plan types. Compared to Volumetric Modulated Arc Therapy, Intensity Modulated Radiotherapy plans required more Monitor Units (MU) on the machine (Table 1). The mean dose to optic chiasm was statistically similar for all three plan types. However, the mean dose to brainstem was significantly lower for 3D Conformal Radiotherapy (1730 cGy) compared to Intensity Modulated Radiotherapy (2970 cGy) and Volumetric Modulated Arc Therapy (2830 cGy). There were no significant differences in the dose to spinal cord for the Intensity Modulated Radiotherapy plans compared to Volumetric Modulated Arc Therapy plans (Table 2). The DVH (dose – volume histogram) for optic chiasm at Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy were very similar. A typical plan for a female patient with an oropharyngeal tumor is shown in Fig. 4. Because VMAT technique uses several radiation fields that means the tumor volume coverage will be better than in case of 3DCRT, besides the treatment time will be much shorter in VMAT case. IV. DISCUSSION Our findings confirmed the expectations that Volumetric Modulated Arc Therapy achieves highly conformal dose Fig. 4. PTV coverage comparison between 3DCRT and VMAT. distribution with better target volume coverage and sparing of normal tissues compared with conventional techniques. In particular, Planning Target Volume coverage was found to be similar for Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy, with both techniques having superior conformity index compared to 3D Conformal Radiotherapy (Table 1). We showed that Volumetric Modulated Arc Therapy required less Monitor Units (MU) on the machine compared to Intensity Modulated Radiotherapy in this study. The lower Monitor Units (MU) is also associated with less interleaf scatter dose and reduced radiotherapy dose to normal tissues, thus minimizing the risk of second radiation-induced malignancies [10] which is of particular relevance when delivering radiotherapy to young patients with oropharyngeal cancer (age range 20–64 in our study). Volumetric Modulated Arc Therapy was found to have similar beam on time compared to Intensity Modulated Radiotherapy and both required more beam on time compared to 3D Conformal Radiotherapy. However, the large number of fixed gantry field with Intensity Modulated Radiotherapy approach increases the total treatment time compared with Volumetric Modulated Arc Therapy and this is likely to impact on intra-fractional patient movement and clinical throughput of the radiotherapy department [11]. As expected the mean dose to brainstem was significantly lower for 3D Conformal Radiotherapy (1730 cGy) compared to Intensity Modulated Radiotherapy (2970 cGy) and Volumetric Modulated Arc Therapy (2830 cGy). Nevertheless, reduced Organs At Risk (OAR) dose is important to minimize late effects. 4 A. Caraman et al. / Journal of Advanced Research in Physics 6(1), 011601 (2016) TABLE I VALUES OF THE CONFORMITY INDEX (CI), HOMOGENITY INDEX (HI) AND CALCULATED MONITOR UNITS (MU) FOR ALL TREATMENT METHODS: 3D CONFORMAL RADIOTHERAPY (3DCRT), VOLUMETRIC MODULATED ARC THERAPY ( VMAT) AND INTENSITY MODULATED RADIOTHERAPY (IMRT) Patient Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Conformity Index (CI) 3DCRT VMAT 1.31 1.07 0.96 1.07 1.29 1.06 1.27 1.06 1.19 1.05 IMRT 1.09 1.20 1.10 1.14 1.18 Homogeneity Index (HI) 3DCRT VMAT IMRT 0.25 0.17 0.11 0.33 0.10 0.09 0.25 0.10 0.09 0.26 0.11 0.10 0.29 0.12 0.09 Monitor Units (MU) 3DCRT VMAT 438 502 308 541 925 539 745 389 310 337 IMRT 1389 1101 1131 1221 1465 TABLE II ORGAN AT RISK (OAR) DOSE EVALUATION FOR ALL TREATMENT METHODS: 3DCRT, VMAT AND IMRT Patient Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Brainstem 3DCRT VMAT (cGy) (cGy) IMRT (cGy) 4200 5170 5470 5330 5900 4900 5900 4920 5200 5000 5000 4630 4940 5900 5870 Maxim admitted value (cGy) 5900 Organs At Risk (OAR) sparing was similar or only slightly better for Volumetric Modulated Arc Therapy compared to Intensity Modulated Radiotherapy in head and neck cancers [9]. The endpoints for the target included mean, minimum, and maximum Planning Target Volume doses. It also included conformity index and homogeneity index. To compare the Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy plans to the original 3D Conformal Radiotherapy plan, dose-volume histograms (DVHs) were used. To visualize the differences, average cumulative DVHs were calculated per examined tumor region for each organ and treatment technique. The investigation for head and neck cancer case using Volumetric Modulated Arc Therapy technique proved a significant sparing of organs at risk and healthy tissue without compromising target volume coverage compared to 3D Conformal Radiotherapy. IMRT (cGy) 4200 4570 4550 4560 4750 3700 4360 4170 4190 4340 3500 4100 3840 4390 4700 Maxim admitted value (cGy) 4500 reduced. This could allow dose escalation by Volumetric Modulated Arc Therapy to tumor in close proximity to the spinal cord, so that local tumor control could be enhanced. In contrast, the reduction of the Organs At Risk (spinal cord) irradiation in 3D Conformal Radiotherapy treatments to avoid the risks of late toxicity necessitates a compromise of the dose to the Planning Target Volume. Apart from the above-mentioned superiority of the Volumetric Modulated Arc Therapy plans, treatment time (beam on and set-up time) and efficiency is another important issue. Since this technique appeared a multitude of people have been treated for cancer. There is no doubt that VMAT technique changed the radiotherapy in better way. REFERENCES [1] [2] V. CONCLUSIONS Our findings show that both Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy provided superior Planning Tumor Volume coverage and improved Organ At Risk (OAR) sparing compared to 3D Conformal Radiotherapy. Volumetric Modulated Arc Therapy was associated with reduced Monitor Units (MU) compared to Intensity Modulated Radiotherapy. Compared to 3D Conformal Radiotherapy plans, Volumetric Modulated Arc Therapy plans provide better dose homogeneity and highly conformal dose distributions. Doses to Organs At Risk (OAR) such as the spinal cord were also Spinal cord 3DCRT VMAT (cGy) (cGy) [3] [4] [5] [6] L. Licitra, J. Bernier, C. Grandi, M. Merlano, P. Bruzzi, and J.L. Lefebvre, “Cancer of the oropharynx”, in Critical Review of Oncology and Hematology, 1, 2002, pp. 107-122. M.L. Gillison, et al., “Evidence for a causal association between human papillomavirus and a subset of head and neck cancers”, J. Natl. Cancer. Inst., 2000, 3, 2000, pp. 265-278, DOI: 10.1093/jnci/92.9.709. J.J. Nuyttens, P.F. Rust, C.R. Thomas Jr, A.T. Turrisi 3rd, “Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles”, Cancer, 14 2000, pp.132-140. World Health Organization IARC monographs on the evaluation of carcinogenic risk to humans. Vol.90: Human papillomaviruses, Ed. Agency for Research on Cancer, Lyon (France), 2007, pp. 350-412. L. Hammarstedt, et al., “Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer”, Int. J. Cancer, 11, 2006, pp.119-125. M. Teoh, C.H. Clark, K. Wood, S. Whitaker, A. Nisbet, “Volumetric modulated arc therapy: a review of current literature and clinical use in practice”, Br. J. Radiol., 84, 2011, pp. 1007-1012, DOI: 10.1259/bjr/22373346. A. Caraman et al. / Journal of Advanced Research in Physics 6(1), 011601 (2016) [7] D. Lindquist, et al., “Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7”, Mol. Oncol. J., 3, 2007, pp. 350-355. [8] B.A. Guadagnolo, G.K. Zagars, M.T. Ball, “Long-term outcomes for desmoid tumors treated with radiation therapy”, Int. J. Radiat. Oncol. Biol. Phys., 88, 2008, pp. 243-268. [9] M.A. Spear, et al., “Individualizing management of aggressive fibromatoses”, Int. J. Radiat. Oncol. Biol. Phys., 40, 1998, pp. 637– 645. [10] C. Chew, R. Reid, P.J. O’Dwyer, “Evaluation of the long term outcome of patients with extremity desmoids” Eur. J. Surg. Oncol., 15, 2004, pp. 163-182. 5